United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$202Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From the SEC filings it signed: 3 on the team.
On the board, as filediAnthony PhilippakisBurt AdelmanJohn EvansKrishna Yeshwant
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Verve Therapeutics's investors include Google Ventures, RA Capital Management, ARCH Venture Partners, Wellington Management and Janus Henderson Investors, and 5 more on record.
Verve Therapeutics has raised $202M across 2 rounds since 2019.
Verve Therapeutics's most recent round was an Undisclosed round of $144M in Nov 2023.
Its most recent round, $144M in Nov 2023, is also its largest on record.
Verve Therapeutics's first round on record, in May 2019, was backed by Google Ventures, F-Prime Capital and Arch and 1 others.
Verve Therapeutics's latest named round is an Undisclosed round, in Nov 2023.
Verve Therapeutics is based in the United States.
Google Ventures led the Series A in 2019.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
